© 2023 MJH Life Sciences and Managed Healthcare Executive. All rights reserved.
© 2023 MJH Life Sciences™ and Managed Healthcare Executive. All rights reserved.
July 18, 2022
A systematic review shows as many as one-third of people with opioid use disorder have concurrent depression, and one-third will have antisocial personality disorder over the course of their lifetimes.
Although one in 12 controlled substances medication transactions at US hospitals involve suspicious variations, only about half of such transactions are ever investigated.
July 15, 2022
The report suggests that smoking by fathers could lead to alterations in their offspring. Male offspring may be more susceptible than female offspring.
June 28, 2022
People who are incarcerated often lack access to a range of opioid use disorder treatments, even though treatment while incarcerated can lead to better outcomes once they are released.
June 23, 2022
Males and older patients were particularly vulnerable, the study found.
June 22, 2022
The findings paint a mixed picture, though, as stimulant use in patients with OUD was also associated with an increased risk of drug poisoning.
April 20, 2022
Patients with cancer who have a poor prognosis may face obstacles in accessing critical pain medications.
July 04, 2020
January 15, 2020
Real-time data provided by Millennium Health will give the U.S. Department of Health and Human Services the opportunity to more quickly alert local health officials about drug trends.
July 26, 2019
Chronic pain patients on opioid therapy have limited access to primary care providers, which could lead to negative outcomes